...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

BREAKING: TransCanna Receives State-Wide Operating License

  • Now owns largest known fully licensed cannabis facilities in California
  • Successfully granted a Type 11 'Distributor' license by the California Bureau of Cannabis Control for its 196,000 square foot Daly Avenue Facility
  • This long-anticipated milestone marks the completion of all state and local licenses required for the Company to begin operations at its flagship cannabis processing facility in Modesto, California

Transcanna dark

Hub On AGORACOM / Read Release

Message: New study in the Lancet regarding COVID 19 and blood clotting

Endotheliopathy in COVID-19 associated coagulopathy: evidence from a single-centre, cross-sectional study

 

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30216-7/fulltext

 

We also know that Apabetalone helps to protect the endothelial system...see :

https://www.resverlogix.com/upload/media_element/195/e0e3e7708c38/2019-10-11-sfn-2019-final.pdf

excerpt:

 

Findings

68 patients with COVID-19 were included in the study from April 13 to April 24, 2020, including 48 ICU and 20 non-ICU patients, as well as 13 non-hospitalised, asymptomatic controls. Markers of endothelial cell and platelet activation were significantly elevated in ICU patients compared with non-ICU patients, including VWF antigen (mean 565% [SD 199] in ICU patients vs 278% [133] in non-ICU patients; p<0·0001) and soluble P-selectin (15·9 ng/mL [4·8] vs 11·2 ng/mL [3·1]; p=0·0014). VWF antigen concentrations were also elevated above the normal range in 16 (80%) of 20 non-ICU patients. We found mortality to be significantly correlated with VWF antigen (r = 0·38; p=0·0022) and soluble thrombomodulin (r = 0·38; p=0·0078) among all patients. In all patients, soluble thrombomodulin concentrations greater than 3·26 ng/mL were associated with lower rates of hospital discharge (22 [88%] of 25 patients with low concentrations vs 13 [52%] of 25 patients with high concentrations; p=0·0050) and lower likelihood of survival on Kaplan–Meier analysis (hazard ratio 5·9, 95% CI 1·9–18·4; p=0·0087).

Interpretation

Our findings show that endotheliopathy is present in COVID-19 and is likely to be associated with critical illness and death. Early identification of endotheliopathy and strategies to mitigate its progression might improve outcomes in COVID-19.

 

Share
New Message
Please login to post a reply